Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 25.95
+0.20 (0.78%)
Mar 10, 2026, 11:25 AM CST
Aurisco Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 616.59 | 769.44 | 545.84 | 391.74 | 444.61 | 564.1 | Upgrade
|
| Trading Asset Securities | 424.24 | 299.83 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,041 | 1,069 | 545.84 | 391.74 | 444.61 | 564.1 | Upgrade
|
| Cash Growth | -7.70% | 95.89% | 39.34% | -11.89% | -21.18% | 112.82% | Upgrade
|
| Accounts Receivable | 398.39 | 350.87 | 290.78 | 222.11 | 140.72 | 142.85 | Upgrade
|
| Other Receivables | 1.89 | 4.23 | 8.31 | 3.9 | 6.19 | 3.91 | Upgrade
|
| Receivables | 400.28 | 355.11 | 299.09 | 226.01 | 146.91 | 146.76 | Upgrade
|
| Inventory | 622.98 | 589.72 | 509.8 | 444.94 | 326.8 | 237.79 | Upgrade
|
| Prepaid Expenses | - | - | - | 0.17 | - | - | Upgrade
|
| Other Current Assets | 18.96 | 32.7 | 11.31 | 25.5 | 21.48 | 29.12 | Upgrade
|
| Total Current Assets | 2,083 | 2,047 | 1,366 | 1,088 | 939.8 | 977.76 | Upgrade
|
| Property, Plant & Equipment | 1,631 | 1,497 | 878.33 | 674.18 | 593.26 | 490.35 | Upgrade
|
| Long-Term Investments | 145.07 | 133.47 | 79.3 | 55.3 | 15.3 | 0.3 | Upgrade
|
| Other Intangible Assets | 158.65 | 161.46 | 121.4 | 122.71 | 40.42 | 41.94 | Upgrade
|
| Long-Term Deferred Tax Assets | 20.29 | 15.78 | 14.29 | 15.24 | 8.56 | 6.3 | Upgrade
|
| Long-Term Deferred Charges | 5.67 | 5.32 | 6.91 | 11.37 | - | - | Upgrade
|
| Other Long-Term Assets | 24.3 | 17.41 | 108.35 | 68.14 | 124.09 | 16.56 | Upgrade
|
| Total Assets | 4,068 | 3,877 | 2,575 | 2,035 | 1,721 | 1,533 | Upgrade
|
| Accounts Payable | 299.56 | 297.39 | 242.53 | 102.43 | 128.2 | 97.05 | Upgrade
|
| Accrued Expenses | 50.08 | 121.64 | 92.89 | 51.95 | 40.89 | 23.13 | Upgrade
|
| Short-Term Debt | 40.03 | 20.02 | 40.04 | 30 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 1.3 | - | - | Upgrade
|
| Current Portion of Leases | 15.97 | 5.64 | 5.14 | 4.93 | 4.06 | - | Upgrade
|
| Current Income Taxes Payable | 24.47 | 25 | 16.64 | 12.85 | 8.61 | 16.94 | Upgrade
|
| Current Unearned Revenue | 4.43 | 6.6 | 22.25 | 0.98 | 8.96 | 1.93 | Upgrade
|
| Other Current Liabilities | 49.82 | 55.74 | 81.53 | 117.75 | 2.36 | 2.57 | Upgrade
|
| Total Current Liabilities | 484.35 | 532.04 | 501.02 | 322.17 | 193.08 | 141.61 | Upgrade
|
| Long-Term Debt | 918.81 | 907.09 | 60.46 | 4.22 | - | - | Upgrade
|
| Long-Term Leases | 16.35 | 15.1 | 11.24 | 12.23 | 13.91 | - | Upgrade
|
| Long-Term Unearned Revenue | 106.07 | 91.57 | 34.02 | 7.69 | 4.53 | 4.14 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.06 | 0.1 | 0.28 | 4.81 | 1.92 | 2.23 | Upgrade
|
| Total Liabilities | 1,527 | 1,546 | 607.03 | 351.13 | 213.44 | 147.98 | Upgrade
|
| Common Stock | 406.2 | 406.2 | 406.2 | 406.2 | 401 | 401 | Upgrade
|
| Additional Paid-In Capital | 613.65 | 606.5 | 584.93 | 553.36 | 491.73 | 489.87 | Upgrade
|
| Retained Earnings | 1,477 | 1,241 | 975.92 | 751.49 | 592.71 | 472.12 | Upgrade
|
| Treasury Stock | -58.47 | -22.86 | -45.72 | -57.15 | - | - | Upgrade
|
| Comprehensive Income & Other | 102.31 | 100.34 | 46.25 | 22.28 | 20.8 | 22.24 | Upgrade
|
| Total Common Equity | 2,541 | 2,332 | 1,968 | 1,676 | 1,506 | 1,385 | Upgrade
|
| Minority Interest | - | - | - | 7.99 | 1.75 | - | Upgrade
|
| Shareholders' Equity | 2,541 | 2,332 | 1,968 | 1,684 | 1,508 | 1,385 | Upgrade
|
| Total Liabilities & Equity | 4,068 | 3,877 | 2,575 | 2,035 | 1,721 | 1,533 | Upgrade
|
| Total Debt | 991.16 | 947.85 | 116.88 | 52.69 | 17.97 | - | Upgrade
|
| Net Cash (Debt) | 49.67 | 121.42 | 428.95 | 339.05 | 426.64 | 564.1 | Upgrade
|
| Net Cash Growth | -81.01% | -71.69% | 26.52% | -20.53% | -24.37% | 112.82% | Upgrade
|
| Net Cash Per Share | 0.12 | 0.30 | 1.05 | 0.84 | 1.06 | 1.51 | Upgrade
|
| Filing Date Shares Outstanding | 406.2 | 406.2 | 406.2 | 406.2 | 401 | 401 | Upgrade
|
| Total Common Shares Outstanding | 406.2 | 406.2 | 406.2 | 406.2 | 401 | 401 | Upgrade
|
| Working Capital | 1,599 | 1,515 | 865.02 | 766.19 | 746.72 | 836.15 | Upgrade
|
| Book Value Per Share | 6.26 | 5.74 | 4.84 | 4.13 | 3.76 | 3.45 | Upgrade
|
| Tangible Book Value | 2,383 | 2,170 | 1,846 | 1,553 | 1,466 | 1,343 | Upgrade
|
| Tangible Book Value Per Share | 5.87 | 5.34 | 4.55 | 3.82 | 3.66 | 3.35 | Upgrade
|
| Buildings | - | 291.81 | 291.85 | 289.74 | 283.37 | 277.72 | Upgrade
|
| Machinery | - | 735.79 | 640.39 | 587.27 | 485.03 | 316.43 | Upgrade
|
| Construction In Progress | - | 869.74 | 280.64 | 79.93 | 47.83 | 90.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.